DIPHTHERIA CRM 197 Protein Conjugate

it is a sterile solution of a conjugate of oligosaccharides of the capsular antigen of Haemophilus influenzae type b (Haemophilus b) and diphtheria CRM 197 protein (CRM 197) dissolved in 0.9% sodium chloride.

Indications

Immunization of children against invasive diseases caused by H. influenzae type b.

Dosage

2-6 Months: Three separate injection of 0.5 ml given at 2 months interval. Unvaccinated: 7-11 months: 2 Separate injection 2 months apart. 12-14 months: One injection. Vaccinated: Single booster dose at 15 months of age or older. 15-71 months: Single injection.

Contra-Indications

Hypersensitivity to any component of the vaccine including diphtheria toxoid, pregnancy and children below 6 weeks.

Special Precautions

Prevent injection into a blood vessel.

Side Effects

Local erythema, warmth or swelling, fever, local reactions, rash, urticaria and tenderness.

Drug Interactions

Anticoagulants.